Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP285605.RAXfwGeU1zv2Rah1u35qGzrcMDpBYIXIKzZo87-5rpSkc130_assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285605.RAXfwGeU1zv2Rah1u35qGzrcMDpBYIXIKzZo87-5rpSkc130_provenance.
• NP623637.RAmTKKz1rxweJPpsWgMc__I1RX0R1DKLsntCMUaiNMs50130_assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623637.RAmTKKz1rxweJPpsWgMc__I1RX0R1DKLsntCMUaiNMs50130_provenance.
• assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP344024.RAWsuucXuxbSFdWJjuGemVxrxWaWXdfViTmYbAAfC74W4130_assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP344024.RAWsuucXuxbSFdWJjuGemVxrxWaWXdfViTmYbAAfC74W4130_provenance.
• NP344032.RASTXIoYJk_fgsTywW5XjmYjfQDpzJ6aE3w2Sc74HUlFk130_assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP344032.RASTXIoYJk_fgsTywW5XjmYjfQDpzJ6aE3w2Sc74HUlFk130_provenance.
• assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP671309.RAXvMGYypI0k0H-lYzQE1UH0ew7X_8LDYgg_JSnJeTUyo130_assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671309.RAXvMGYypI0k0H-lYzQE1UH0ew7X_8LDYgg_JSnJeTUyo130_provenance.
• NP671310.RAb8PnHKvR8TVFJ1Z7ISUV3Z3X1dpoksfB-Bt6rir1xWA130_assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671310.RAb8PnHKvR8TVFJ1Z7ISUV3Z3X1dpoksfB-Bt6rir1xWA130_provenance.
• NP671311.RASAYgwEr6bkOvkyigzWVy64mc7p4EW2-D03fmMl3oTVU130_assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671311.RASAYgwEr6bkOvkyigzWVy64mc7p4EW2-D03fmMl3oTVU130_provenance.
• NP671306.RAAYh7RByOigqluEVccG862riDZpsYEE3zZgBDMkW1EMk130_assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671306.RAAYh7RByOigqluEVccG862riDZpsYEE3zZgBDMkW1EMk130_provenance.
• NP344477.RAvfrU2g7OBF6O6S2Yo8yH_SF3IOibNzA-9Ua-L5O-dL4130_assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP344477.RAvfrU2g7OBF6O6S2Yo8yH_SF3IOibNzA-9Ua-L5O-dL4130_provenance.
• NP466104.RAJcuwRjL9vZMRy3Ghm7an5k3dSrsXfX71R2qqOOXw39g130_assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP466104.RAJcuwRjL9vZMRy3Ghm7an5k3dSrsXfX71R2qqOOXw39g130_provenance.
• NP466110.RAx9wQ1iq78U6vCtvP3mri-pieG2RotEjXDuNeLb5Twjc130_assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP466110.RAx9wQ1iq78U6vCtvP3mri-pieG2RotEjXDuNeLb5Twjc130_provenance.
• NP466143.RA0o5_vOPq1wQ-u62XtAQW1Ul6Nrau0u6ZnTuRcb06ckE130_assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP466143.RA0o5_vOPq1wQ-u62XtAQW1Ul6Nrau0u6ZnTuRcb06ckE130_provenance.
• NP671314.RAPTTEzJgyB6FmnvC2qUonplUgdPtuYT1wmUzpFJ_pobM130_assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671314.RAPTTEzJgyB6FmnvC2qUonplUgdPtuYT1wmUzpFJ_pobM130_provenance.
• NP671307.RA3sZHKfhTt6YGciVtKKFpMaJlXUAdAHLmwCkcV-BHJcs130_assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671307.RA3sZHKfhTt6YGciVtKKFpMaJlXUAdAHLmwCkcV-BHJcs130_provenance.